Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation

16Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A 39-year-old male, who received a facial allograft (cytomegalovirus [CMV] donor-seropositive, recipient-seronegative), developed multidrug-resistant CMV infection despite valganciclovir prophylaxis (900 mg/day) 6 months post transplantation. Lower extremity weakness with upper and lower extremity paresthesias developed progressively 11 months post transplantation, coinciding with immune control of CMV. An axonal form of Guillain-Barré syndrome was diagnosed, based on electrophysiological evidence of a generalized, non-length-dependent, sensorimotor axonal polyneuropathy. Treatment with intravenous immunoglobulin led to complete recovery without recurrence after 6 months.

Cite

CITATION STYLE

APA

Alhefzi, M., Aycart, M. A., Bueno, E. M., Kueckelhaus, M., Fischer, S., Snook, R. J., … Marty, F. M. (2016). Guillain-Barré syndrome associated with resistant cytomegalovirus infection after face transplantation. Transplant Infectious Disease, 18(2), 288–292. https://doi.org/10.1111/tid.12516

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free